RHY 1.10% 9.2¢ rhythm biosciences limited

on the way to $1, page-24

  1. 2,371 Posts.
    lightbulb Created with Sketch. 229
    Hey everyone hope someone with a little more insight can help me here.

    I'm wondering why the stage 5 trial didn't work out. The prospectus seems to blame one of the biomarkers not performing as expected.

    I can see there's a lot of collaboration with CSIRO to develop the final biomarker / antibodies and confirm that they can be sustainably produced (supply chain control).

    Again from the prospectus and a recent announcement I can see that stage 6 will apply the new biomarker / antibodies to the samples from stage 5 trial to confirm success. At the same time stage 7 (1000 person trial) will begin to be organised concurrently to save time.

    Does someone have a handle on, or has spoken to the company about why stage 5 trial didn't work out specifically and why they are confident that the new biomarker developed by CSIRO will succeed when applied to stage 5 samples?

    Obviously they're trying to keep the timeline going though if the new biomarker from CSIRO doesn't work as expected when they apply it to the stage 5 samples to confirm success, then timelines will be pushed out quite a lot as the stage 7 trial will need to be pushed back.

    Any thoughts would be welcome. I've read the research note shared in the thread though I don't believe it addressed this series of questions.

    Cheers

    Screen Shot 2018-06-05 at 1.29.01 pm.png

    Screen Shot 2018-06-05 at 1.30.32 pm.png
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.001(1.10%)
Mkt cap ! $15.41M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $86.23K 927.6K

Buyers (Bids)

No. Vol. Price($)
1 200000 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 1000 1
View Market Depth
Last trade - 15.57pm 29/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.